I was not intending to comment on #AVCT again until more solid news-flow, but I& #39;ve had numerous messages today about the current 14% drop in the SP.

For me, it& #39;s simply down to the "Avacta has missed the #COVID19 boat" brigade. Two news tests announced by Gov and people... 1/5

...assume there& #39;ll be no requirement for #AVCT& #39;s LFT.

Oxford Nanopore& #39;s test out today takes 90-120 mins (AVCT& #39;s = 10-20 mins); requires nasal swab samples (AVCT& #39;s = saliva); and requires a machine to process (albeit small - but AVCT& #39;s LFT will be straight out a packet). 2/5

UK Gov has needed a big win on the testing front, given the multiple **** ups it& #39;s orchestrated in recent months.

Hence the media blitz today, with "Gamechanger" being plastered everywhere.

Let& #39;s be honest: an accurate, cheap LFT will be The Gamechanger. There is none yet...3/5

...in existence.

Not only is #AVCT v likely to one of the first to market (OraSure and $SONA are competition), but is likely to have the most accurate test.

For me, today& #39;s news should be evidence that WHEN it& #39;s ready, the UK Gov& #39;s orders for #AVCT& #39;s LFT could be gargantuan 4/5

It& #39;s frustrating to see the SP down again, but as I& #39;ve mentioned, AIM is irrational. I& #39;ve learned that being able to endure the ugly periods, through perceiving the market& #39;s irrationality, will often enable you to reap the greatest rewards.

#AVCT is now a perfect example. 5/5